Trials / Recruiting
RecruitingNCT07414342
Safety and Efficacy of the RENATUS® Transcatheter Aortic Valve System for the Treatment of Severe Aortic Stenosis
- Status
- Recruiting
- Phase
- N/A
- Study type
- Interventional
- Enrollment
- 800 (estimated)
- Sponsor
- Beijing Balance Medical Technology Co., Ltd · Industry
- Sex
- All
- Age
- 60 Years – 100 Years
- Healthy volunteers
- Not accepted
Summary
This study is a prospective, non-randomized, observational, post-market follow-up trial designed to evaluate the safety and efficacy of the RENATUS® Transcatheter Aortic Valve System for the treatment of severe aortic stenosis.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DEVICE | RENATUS® TAVR | RENATUS® Transcatheter Aortic Valve System，an approved marketed TAVR |
Timeline
- Start date
- 2026-02-01
- Primary completion
- 2027-09-01
- Completion
- 2037-09-01
- First posted
- 2026-02-17
- Last updated
- 2026-02-17
Locations
4 sites across 1 country: China
Source: ClinicalTrials.gov record NCT07414342. Inclusion in this directory is not an endorsement.